SCHEMBL1357607

SCHEMBL1357607

O=C(CCl)Nc1nc(-c2ccccc2)cs1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELOVL1 Q9BW60 2/20 0.72
▸ MAPT P10636 4/20 0.69
▸ MAPK1 P28482 2/20 0.66
▸ HDAC3 O15379 2/20 0.66
▸ HDAC4 P56524 2/20 0.66
▸ HDAC1 Q13547 2/20 0.66
▸ HDAC7 Q8WUI4 2/20 0.66
▸ HDAC2 Q92769 2/20 0.66
▸ HDAC10 Q969S8 2/20 0.66
▸ HDAC11 Q96DB2 2/20 0.66
▸ HDAC8 Q9BY41 2/20 0.66
▸ HDAC6 Q9UBN7 2/20 0.66
▸ HDAC9 Q9UKV0 2/20 0.66
▸ HDAC5 Q9UQL6 2/20 0.66
▸ NPC1 O15118 2/20 0.66
▸ USP2 O75604 1/20 0.66
▸ ALDH1A1 P00352 1/20 0.66
▸ PKM P14618 1/20 0.66
▸ ALOX15 P16050 1/20 0.66
▸ MEN1 O00255 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31496767 0.89 HDAC1 (0.70) ELOVL1MAPTMAPK1HDAC3HDAC4
SCHEMBL3255629 0.88 WNT3A (0.69) MAPTHDAC1HDAC2ALDH1A1MEN1
SCHEMBL6610860 0.87 ABL1 (0.70) MAPTMAPK1NPC1USP2ALDH1A1
SCHEMBL225327 0.87 ELOVL1 (0.74) ELOVL1MAPTMAPK1HDAC3HDAC4
SCHEMBL11790758 0.86 ALDH1A1 (0.69) MAPTMAPK1HDAC3HDAC4HDAC1
SCHEMBL28643881 0.86 HDAC1 (0.66) MAPTMAPK1HDAC1HDAC9NPC1
SCHEMBL8402291 0.85 MAPT (0.73) ELOVL1MAPTMAPK1HDAC3HDAC4
SCHEMBL2452315 0.85 ELOVL1 (0.72) ELOVL1MAPTMAPK1HDAC3HDAC4
SCHEMBL21224224 0.85 ELOVL1 (0.72) ELOVL1MAPTMAPK1HDAC3HDAC4
SCHEMBL19380614 0.84 ELOVL1 (1.00) ELOVL1MAPTMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10611733-B2 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2020-04-07 — — US disclosed
EP-3424912-A1 2-AMINOTHIAZOLE DERIVATIVES FOR MEDICAL USE Huazhong University of Science and Technology (CN) 2019-01-09 — — EP disclosed
US-9771340-B2 2-aminothiazole derivatives and methods of preparing and using the same WUHAN INNAMUNE PHARMACEUTICAL CO., LTD. (CN) 2017-09-26 — — US disclosed
US-20170144978-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RESEARCH INSTITUTE 2017-05-25 — — US disclosed
US-20170144978-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RESEARCH INSTITUTE 2017-05-25 — — US disclosed
US-9598402-B2 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections SOUTHERN RESEARCH INSTITUTE (US) 2017-03-21 — — US disclosed
US-9598402-B2 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections SOUTHERN RESEARCH INSTITUTE (US) 2017-03-21 — — US disclosed
EP-2744787-B1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RES INST (US) 2016-11-02 — — EP disclosed
CN-102336720-B Thiazolamine derivative and preparation method and application HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2016-01-13 — — CN disclosed
US-20140256753-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-09-11 — — US disclosed
EP-2682390-A1 2-AMINOTHIAZOLE DERIVATIVE, PREPARATION METHOD, AND USE Huazhong University of Science and Technology (CN) 2014-01-08 — — EP disclosed
US-20140004155-A1 2-AMINOTHIAZOLE DERIVATIVES AND METHODS OF PREPARING AND USING THE SAME HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO., LTD. (CN) 2014-01-02 — — US disclosed
US-8481577-B2 Amide thiazole derivative, preparation method and uses thereof TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) 2013-07-09 — — US disclosed
EP-2404909-B1 AMIDE THIAZOLE DERIVATIVE, PREPARATION METHOD AND USES THEREOF TIANJIN INST PHARM RESEARCH (CN) 2013-05-29 — — EP disclosed
WO-2013025508-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RESEARCH INSTITUTE (US) 2013-02-21 — — WO disclosed
WO-2013025508-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RESEARCH INSTITUTE (US) 2013-02-21 — — WO disclosed
CN-102351854-A Amino thiazole derivative and preparation method and medical purpose thereof UNIV HUAZHONG SCIENCE TECH 2012-02-15 — — CN disclosed
CN-102336720-A 2-aminothiazole derivatives, and preparation method and application thereof UNIV HUAZHONG SCIENCE TECH 2012-02-01 — — CN disclosed
EP-2404909-A1 AMIDE THIAZOLE DERIVATIVE, PREPARATION METHOD AND USES THEREOF Tianjin Institute Of Pharmaceutical Research (CN) 2012-01-11 — — EP disclosed
US-20110281922-A1 AMIDE THIAZOLE DERIVATIVE, PREPARATION METHOD AND USES THEREOF TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) 2011-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281922-A1 AMIDE THIAZOLE DERIVATIVE, PREPARATION METHOD AND USES THEREOF DPP4, DPP3, DPP7 ELOVL1 1900/4885MAPT 2411/4885MAPK1 2719/4885
US-20140256753-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS HAVCR2, EIF2AK2, GLS2 ELOVL1 2457/4885MAPT 1316/4885MAPK1 1937/4885
US-20170144978-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS ZC3HAV1, EIF2AK2, GTF3C3 ELOVL1 2179/4885MAPT 1974/4885MAPK1 2987/4885
US-10611733-B2 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections ZC3HAV1, EIF2AK2, GTF3C3 ELOVL1 2179/4885MAPT 1974/4885MAPK1 2987/4885
US-20140004155-A1 2-AMINOTHIAZOLE DERIVATIVES AND METHODS OF PREPARING AND USING THE SAME CCNT1, CCNE1, CCNT2 ELOVL1 3796/4885MAPT 1485/4885MAPK1 2273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback